Registration - Consultant

Pharmascience Inc. / Pharmascience Inc. / Delaney Cullinan, Consultant

Registration Information

Client name: Pharmascience Inc. / Pharmascience Inc.
Lobbyist name: Delaney Cullinan, Consultant
Initial registration start date: 2023-05-02
Registration status: Active
Registration Number: 948090-374556

Associated Communications

Total Number of Communication Reports: 0

Monthly communication reports in the last 6 months: 0

Version 1 of 4 (2023-05-02 to 2024-03-26)

Registration versions:

Version 1 of 4 (2023-05-02 to 2024-03-26)

Lobbying Information

Subject Matters

Economic Development
Government Procurement
Health
Industry
Intellectual Property
International Trade
Municipalities
Regional Development
Research and Development
Science and Technology
Taxation and Finance

Subject Matter Details

Grant, Contribution or Other Financial Benefit

Seeking support from the Strategic Innovation Fund Program for support of biomanufacturing expansion project.

Policies or Program

Discussion of a possible Therapeutics Products Directorate ("TPD") workstream on complex generics regulatory pathways.
Discussion of regulatory impediments to the launch of pediatric formulations of branded and generic products.
Discussion on the opioids crisis and the Health minister's expectations from pharmaceutical manufacturers
Policies aimed at facilitating generic drugs repurposing.
Policies aimed at reinforcing pharmaceutical supply chain.

Communication Techniques

Written communication
Oral communication

The lobbyist has arranged or expects to arrange one or more meetings on behalf of the client between a public office holder and any other person in the course of this undertaking.

Government Institutions

Finance Canada (FIN)
Global Affairs Canada (GAC)
Health Canada (HC)
House of Commons
Innovation, Science and Economic Development Canada (ISED)
Prime Minister's Office (PMO)
Senate of Canada
Transport Canada (TC)

Client Details

Government funding

No government funding was received during the last completed financial year.

Client Contact Information

Address:
6111 Royalmount avenue, suite 100
Montreal, QC H4P 2T4
Canada

Telephone number: 514-340-9800
Web address: https://www.pharmascience.com

Client representative

David Goodman, Chief Executive Officer

Parent Company Information

Joddes Limited
- 6111 Royalmount avenue, suite 100
  Montreal, QC H4P 2T4
  Canada

Coalition Members Information

Pharmascience Inc. / Pharmascience Inc. is not a coalition.

Individual, organization or corporation with a Direct Interest Beneficiary Information

The activities of Pharmascience Inc. / Pharmascience Inc. are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.

Subsidiary Beneficiary Information

Pharmascience Inc. / Pharmascience Inc. does not have any subsidiaries that could have a direct interest in the outcome of the undertaking

Lobbyist Details

Delaney Cullinan | No public offices held

Business address:
46 Elgin Street, suite 200
Ottawa, ON K1P 5K6
Canada

Telephone number: 613-563-4455 Ext. 221

Consultant Firm and Address

Firm: Earnscliffe Strategy Group

Address:
46 Elgin Street, suite 200
Ottawa, ON K1P 5K6
Canada

Telephone number: 613-563-4455 Ext. 221

Pharmascience Inc./Pharmascience Inc.

The following names have been used on or after July 2, 2008

The following names have been used on or after July 2, 2008
Name	From	To
Pharmascience Inc./Pharmascience Inc.	2024-07-23	current
Pharmascience Inc./Pharmascience Inc.	2023-05-02	2024-07-23

Pharmascience Inc. / Pharmascience Inc.

Responsible Officer History
Responsible Officer Name	From (YYYY-MM-DD)	To (YYYY-MM-DD)

Date Modified:: 2024-04-04

Search and menus

Language selection

Registration - Consultant

Pharmascience Inc. / Pharmascience Inc. / Delaney Cullinan, Consultant

Registration Information

Associated Communications

Version 1 of 4 (2023-05-02 to 2024-03-26)

Version 1 of 4 (2023-05-02 to 2024-03-26)

Subject Matters

Subject Matter Details

Grant, Contribution or Other Financial Benefit

Policies or Program

Communication Techniques

Government Institutions

Government funding

Client Contact Information

Client representative

Parent Company Information

Coalition Members Information

Individual, organization or corporation with a Direct Interest Beneficiary Information

Subsidiary Beneficiary Information

Consultant Firm and Address

Registration - Consultant

Pharmascience Inc. / Pharmascience Inc. / Delaney Cullinan, Consultant

Version 1 of 4 (2023-05-02 to 2024-03-26)

Subject Matters

Subject Matter Details

Grant, Contribution or Other Financial Benefit

Policies or Program

Communication Techniques

Government Institutions

Government funding

Client Contact Information

Client representative

Parent Company Information

Coalition Members Information

Individual, organization or corporation with a Direct Interest Beneficiary Information

Subsidiary Beneficiary Information

Consultant Firm and Address

Pharmascience Inc./Pharmascience Inc.

The following names have been used on or after July 2, 2008

Pharmascience Inc. / Pharmascience Inc.

Delaney Cullinan, Earnscliffe Strategy Group (Consultant)